Prevention of cardiovascular diseases in elderly subjects with hyperlipidaemia;Prévention des maladies cardiovasculaires chez le sujet âgé hypercholestérolémique

Therapie

Volumn 55, Issue 6, 2000, Pages 669-674

  Bruckert, E ^a   Giral, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiovascular disease; Cholesterol; Elderly subject; Hyperlipidaemia

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

AGED; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COST BENEFIT ANALYSIS; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MORBIDITY; PRIORITY JOURNAL; REVIEW;

AGE DISTRIBUTION; AGED; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; RISK FACTORS;

EID: 0034476923     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. To treat or not to treat dyslipidemia in the asymptomatic elderly
2. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
3. Guidelines for using serum cholesterol, high density lipoprotein, and triglyceride levels as screening tests for preventing coronary heart disease in adults
4. International trends in cardiovascular diseases in the elderly
5. Coronary heart disease in the elderly: The magnitude of the problem in the United States
6. Cardiovascular risk factors in the elderly
7. Prevalence of chronic diseases in older Italians
8. Epidemiology of coronary heart disease in the elderly
9. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis
10. HMG-CoA reductase inhibitors in the prevention of stroke
11. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial
12. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEp)
13. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
14. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop
15. Cholesterol and mortality: 30 years of follow-up from the Framingham study
16. Proportional hazard analysis of risk factors for coronary disease in individuals aged 65 or older
17. Treating high blood cholesterol in the older patients
18. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly
19. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study
20. Fasting serum cholesterol and triglycerides in a ten year prospective study in old age
21. Ischemic heart disease risk factors after age 50
22. Relationship between plasma lipids and the incidence of cardiovascular events in the old: The Bronx longitudinal aging study
23. Cholesterol as risk factor for mortality in elderly women
24. Prognostic significance of serum cholesterol in nursing home men
25. Risk factors for 5-year mortality in older adults. The Cardiovascular Health Study
26. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
27. Why does plasma low density lipoprotein concentration in adults increase with age?
28. Nutritional contributors to cardiovascular disease
29. Increase in cholesterol intestinal absorption with aging in the rat
30. Kinetic mechanisms determining variability in low density lipoprotein levels and rising with age
31. A longitudinal study of nutritional intake in men
32. Cholesterol metabolism and aging
33. Evidence for inflammation as a cause of hypocholesterolemia in older people
34. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
35. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
36. Prevention of cardiovascular events death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
37. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
38. Simvastatin therapy for type II hyperlipoproteinemia on a long term basis in elderly
39. Drug treatment of hyperlipidemia in elderly patients
40. Elderly patients with hypercholesterolemia: A double-blind study of the efficacy, safety and tolerability of fluvastatin
41. Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction In Seniors Program (CRISP) pilot study
42. Targeting lipid lowering drug therapy for primary prevention of coronary heart disease: An updated Sheffield table
43. The quality of life in the year before death